Cover Image
Market Research Report

Global Assisted Reproductive Technology Market 2020-2024

Published by TechNavio (Infiniti Research Ltd.) Product code 475018
Published Content info 120 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Assisted Reproductive Technology Market 2020-2024
Published: March 17, 2020 Content info: 120 Pages
Description

Technavio has been monitoring the global assisted reproductive technology market 2020-2024 and it is poised to grow by USD 6.31 bn during 2020-2024, progressing at a CAGR of 4% during the forecast period. Our reports on global assisted reproductive technology market 2020-2024 provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in rate of infertility and obesity related cases. In addition, increase in awareness of art is anticipated to boost the growth of the global assisted reproductive technology market 2020-2024 as well.

Market Segmentation

Technavio's ‘ global assisted reproductive technology market 2020-2024 ’ is segmented as below:

Application:

  • Fertility Clinics
  • Hospitals
  • Others

Geographic segmentation

  • APAC
  • Europe
  • MEA
  • North America
  • South America

Key Trends for global assisted reproductive technology market 2020-2024 growth

This study identifies increase in awareness of art as the prime reasons driving the global assisted reproductive technology market 2020-2024 growth during the next few years.

Prominent vendors in global assisted reproductive technology market 2020-2024

We provide a detailed analysis of around 25 vendors operating in the global assisted reproductive technology market 2020-2024, including some of the vendors such as Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd, FUJIFILM Holdings Corp., INVO Bioscience Inc, Merck KGaA, Monash IVF Group Ltd., The Cooper Companies Inc., Virtus Health Ltd. and Vitrolife AB .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Table of Contents
Product Code: IRTNTR41430

Table of Contents

Executive Summary

  • Market Overview

Market Landscape

  • Market ecosystem
  • Value chain analysis

Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Fertility clinics - Market size and forecast 2019-2024
  • Hospitals - Market size and forecast 2019-2024
  • Others - Market size and forecast 2019-2024
  • Market opportunity by Application

Customer landscape

  • Overview

Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • Europe - Market size and forecast 2019-2024
  • North America - Market size and forecast 2019-2024
  • APAC - Market size and forecast 2019-2024
  • South America - Market size and forecast 2019-2024
  • MEA - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography

Drivers, Challenges, and Trends

  • Market drivers
  • Volume driver - Demand led growth
  • Volume driver - Supply led growth
  • Volume driver - External factors
  • Volume driver - Demand shift in adjacent markets
  • Price driver - Inflation
  • Price driver - Shift from lower to higher-priced units
  • Market challenges
  • Market trends

Vendor Landscape

  • Overview
  • Landscape disruption

Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • Anecova SA
  • CRITEX GmbH
  • Esco Micro Pte. Ltd
  • FUJIFILM Holdings Corp.
  • INVO Bioscience Inc
  • Merck KGaA
  • Monash IVF Group Ltd.
  • The Cooper Companies Inc.
  • Virtus Health Ltd.
  • Vitrolife AB

Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

List of Exhibits:

  • 1.Key Finding 1
  • 2.Key Finding 2
  • 3.Key Finding 3
  • 4.Key Finding 5
  • 5.Key Finding 6
  • 6.Key Finding 7
  • 7.Key Finding 8
  • 8.Market in focus
  • 10.Parent market
  • 13.Market characteristics
  • 15.Offerings of vendors included in the market definition
  • 17.Market segments
  • 22.Global - Market size and forecast 2019 - 2024 ($ billion)
  • 23.Global market: Year-over-year growth 2019 - 2024 (%)
  • 24.Five forces analysis 2019 & 2024
  • 27.Bargaining power of buyers
  • 29.Bargaining power of suppliers
  • 30.Threat of new entrants
  • 31.Threat of substitutes
  • 32.Threat of rivalry
  • 34.Market condition - Five forces 2019
  • 36.Application placement - Market share 2019-2024 (%)
  • 37.Comparison by Application
  • 40.Fertility clinics - Market size and forecast 2019-2024 ($ billion)
  • 41.Fertility clinics - Year-over-year growth 2019-2024 (%)
  • 44.Hospitals - Market size and forecast 2019-2024 ($ billion)
  • 45.Hospitals - Year-over-year growth 2019-2024 (%)
  • 48.Others - Market size and forecast 2019-2024 ($ billion)
  • 49.Others - Year-over-year growth 2019-2024 (%)
  • 51. Market opportunity by Application
  • 52.Customer landscape
  • 54.Market share by geography 2019-2024 (%)
  • 55.Geographic comparison
  • 58.Europe - Market size and forecast 2019-2024 ($ billion)
  • 60.Europe - Year-over-year growth 2019-2024 (%)
  • 63.North America - Market size and forecast 2019-2024 ($ billion)
  • 65.North America - Year-over-year growth 2019-2024 (%)
  • 68.APAC - Market size and forecast 2019-2024 ($ billion)
  • 70.APAC - Year-over-year growth 2019-2024 (%)
  • 73.South America - Market size and forecast 2019-2024 ($ billion)
  • 75.South America - Year-over-year growth 2019-2024 (%)
  • 78.MEA - Market size and forecast 2019-2024 ($ billion)
  • 80.MEA - Year-over-year growth 2019-2024 (%)
  • 82.Key leading countries
  • 84.Market opportunity by geography ($ billion)
  • 85.Impact of drivers and challenges
  • 86.Vendor landscape
  • 88.Landscape disruption
  • 90.Industry risks
  • 92.Vendors covered
  • 94.Market positioning of vendors
  • 96.Anecova SA - Overview
  • 97.Anecova SA - Product and service
  • 98.Anecova SA - Key offerings
  • 99.Anecova SA - Key customers
  • 100.Anecova SA - Segment focus
  • 102.CRITEX GmbH - Overview
  • 103.CRITEX GmbH - Product and service
  • 104.CRITEX GmbH - Key offerings
  • 105.CRITEX GmbH - Key customers
  • 106.CRITEX GmbH - Segment focus
  • 108.Esco Micro Pte. Ltd - Overview
  • 109.Esco Micro Pte. Ltd - Product and service
  • 110.Esco Micro Pte. Ltd - Key offerings
  • 111.Esco Micro Pte. Ltd - Key customers
  • 112.Esco Micro Pte. Ltd - Segment focus
  • 114.FUJIFILM Holdings Corp. - Overview
  • 115.FUJIFILM Holdings Corp. - Business segments
  • 116.FUJIFILM Holdings Corp. - Key offerings
  • 117.FUJIFILM Holdings Corp. - Key customers
  • 118.FUJIFILM Holdings Corp. - Segment focus
  • 120.INVO Bioscience Inc - Overview
  • 121.INVO Bioscience Inc - Product and service
  • 122.INVO Bioscience Inc - Key offerings
  • 123.INVO Bioscience Inc - Key customers
  • 124.INVO Bioscience Inc - Segment focus
  • 126.Merck KGaA - Overview
  • 127.Merck KGaA - Business segments
  • 128.Merck KGaA - Key offerings
  • 129.Merck KGaA - Key customers
  • 130.Merck KGaA - Segment focus
  • 132.Monash IVF Group Ltd. - Overview
  • 133.Monash IVF Group Ltd. - Business segments
  • 134.Monash IVF Group Ltd. - Key offerings
  • 135.Monash IVF Group Ltd. - Key customers
  • 136.Monash IVF Group Ltd. - Segment focus
  • 138.The Cooper Companies Inc. - Overview
  • 139.The Cooper Companies Inc. - Business segments
  • 140.The Cooper Companies Inc. - Key offerings
  • 141.The Cooper Companies Inc. - Key customers
  • 142.The Cooper Companies Inc. - Segment focus
  • 144.Virtus Health Ltd. - Overview
  • 145.Virtus Health Ltd. - Business segments
  • 146.Virtus Health Ltd. - Key offerings
  • 147.Virtus Health Ltd. - Key customers
  • 148.Virtus Health Ltd. - Segment focus
  • 150.Vitrolife AB - Overview
  • 151.Vitrolife AB - Business segments
  • 152.Vitrolife AB - Key offerings
  • 153.Vitrolife AB - Key customers
  • 154.Vitrolife AB - Segment focus
  • 156.Currency conversion rates for US$
  • 157.Research Methodology
  • 158.Validation techniques employed for market sizing
  • 159.Information sources
  • 160. List of abbreviations
Back to Top